Ledger.Open graph →

SEC Form D · filed October 15, 2014

PROVECTUS BIOPHARMACEUTICALS, INC

Offering

$15.0M

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

KNOXVILLE, TN

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Eric A. Wachter · Knoxville, TNExec Peter R. Culpepper · Knoxville, TNExec Jan C. Koe · Knoxville, TNDirector Kelly M. Mcmasters · Knoxville, TNDirector Alfred E. Smith Iv · Knoxville, TNDirector H. C. Dees · Knoxville, TNExec · Director Nancy K. Naeve · IRVINE, CADirector Raffi Asadorian · EMERYVILLE, CADirector Philippe Boisseau · EMERYVILLE, CAExec · Director Brian A. Dahn · IRVINE, CAExec Inderjit Singh · Grand Cayman, Cayman IslandsExec Tim A. Scott · Knoxville, TNExec Elizabeth T. Gile · New York, NYExec Dahn America360, LLC · IRVINE, CAExec Fernando J. Reinach · EMERYVILLE, CADirector Joel Cherry · EMERYVILLE, CADirector Geoffrey J. Duyk · EMERYVILLE, CADirector Raleigh A. Shoemaker · BOSTON, MAExec · Director Tim A. Scott · Knoxville, TNExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗